GSK5764227 Clinical Trials
5 recruitingBiologic
Phase 14Phase 22
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Comprehensive Multiomic Biomarker Evaluation Across Two Single-arm Cohorts to Elucidate Mechanisms of Response and Resistance in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma
University Health Network, Toronto30 enrolled1 locationNCT07408063
Recruiting
Phase 1
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
Neoplasms
GlaxoSmithKline84 enrolled6 locationsNCT07277270
Recruiting
Phase 1
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Neoplasms
GlaxoSmithKline158 enrolled26 locationsNCT05277051
Recruiting
Phase 1
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101)
Neoplasms
GlaxoSmithKline590 enrolled53 locationsNCT06551142
Recruiting
Phase 1Phase 2
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed
Gastrointestinal Neoplasms
GlaxoSmithKline320 enrolled47 locationsNCT06885034